• Eerdun Wurile and PI3K/AKT in Brain Hemorrhage

  2026-09-09

  A 2026 study reports that the Mongolian medicine Eerdun Wurile reduces neurological deficits, neuronal apoptosis, neuroinflammation, blood–brain barrier disruption, and synaptic injury after intracerebral hemorrhage in mouse and cell models. Integrated behavioral, histological, and RNA-sequencing analyses identify PI3K/AKT signaling and Bcl-2-family regulation as a mechanistic framework for its neuroprotective effects.

• Tunicamycin for Reliable ER Stress Assays

  2026-09-09

  Learn how Tunicamycin, including SKU B7417, can improve interpretation of viability, proliferation, macrophage inflammation, and ER-stress experiments. This scenario-based guide connects mechanism, preparation, controls, and vendor-selection criteria with current glycosylation research.

• Liproxstatin-1: A Translational Ferroptosis Strategy

  2026-09-08

  Liproxstatin-1 is more than a pathway rescue reagent: it can help translational researchers distinguish lipid-peroxidation-driven injury from broader oxidative or regulated cell death. This article connects its validated ferroptosis activity with experimental design, renal injury modeling, and the emerging cuproptosis landscape.

• Estradiol: ER Signaling and Research Use

  2026-09-08

  Estradiol, also called 17 beta-estradiol, is an endogenous steroid that activates ERα and ERβ to regulate gene expression and rapid cellular signaling. Research evidence connects estrogen receptor activity with autophagy, tissue fibrosis, vascular biology, and hormone-dependent cell responses, but observational associations do not establish clinical causality.

• Rosemary-Root Lignans and Anti-Inflammatory Activity

  2026-09-07

  A January 2026 Fitoterapia study characterized eight lignans and four phenylpropanoids from Rosmarinus officinalis roots, including the new rosmarinicols A–C. Six compounds reduced nitric oxide production in LPS-stimulated RAW264.7 macrophages, providing a chemically defined starting point for anti-inflammatory research while leaving molecular targets and in vivo relevance unresolved.

• Paroxetine Mesylate in Cell Assay Design

  2026-09-07

  This scenario-based guide explains how Paroxetine Mesylate (SKU C8698) can support interpretable cell viability, proliferation, and cytotoxicity experiments while accounting for its multi-target pharmacology. It connects concentration-response design, storage, orthogonal validation, translational limits, and practical supplier selection.

• METTL17, Mitochondrial Translation, and CRC Ferroptosis

  2026-09-05

  The reference study identifies METTL17 as a mitochondrial regulator that supports colorectal cancer growth and resistance to ferroptosis by sustaining mitochondrial RNA methylation and protein translation. Its combination of cell, animal, and molecular evidence positions METTL17-dependent mitochondrial maintenance as a potential vulnerability for ferroptosis-based colorectal cancer research.

• How In Vitro Drug Response Metrics Improve Cancer Studies

  2026-09-04

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of anticancer drug response. This framework helps researchers design assays that resolve response magnitude, mechanism, and timing rather than treating a single viability endpoint as a direct measure of cell killing.

• Erlotinib (NSC 718781) in EGFR Research

  2026-09-04

  Erlotinib provides a precise small-molecule probe for EGFR kinase activity, connecting phospho-signaling measurements with proliferation, apoptosis, and resistance studies. This workflow shows how to use it as an EGFR pathway comparator in SCUBE3-driven cancer models without mistaking downstream pathway suppression for direct SCUBE3 neutralization.

• Biotin-XX Tyramide Reagent: Reliable Cell-Surface Assays

  2026-09-03

  Biotin-XX Tyramide Reagent (SKU A8012) offers membrane-impermeant, HRP-mediated signal amplification for low-abundance cell-surface targets in fixed-cell workflows. This scenario-driven guide explains selection, handling, controls, and interpretation for researchers connecting viability or cytotoxicity phenotypes with surface-protein measurements.

• Norovirus Co-opts NINJ1 for Selective NS1 Secretion

  2026-09-03

  Song and colleagues show that murine norovirus repurposes the membrane-rupture factor NINJ1 to release the interferon-antagonistic protein NS1, while still producing broad damage-associated molecular pattern release. The study combines CRISPR screening, caspase-3 perturbation, imaging, protein mutagenesis, and mouse infection models to connect viral protein secretion with enteric pathogenesis.

• CXCR4–EGFR Heteromers Rewire Cancer Signaling

  2026-09-02

  Comez et al. show that CXCR4 and EGFR assemble into ligand-responsive oligomeric signaling complexes rather than functioning only as independent receptors. NanoBRET, nanobody-based proximity ligation assays, and functional coupling measurements link these complexes to PLCγ, Gi proteins, and β-arrestin-2, with endogenous receptor proximity confirmed in HeLa cells.

• Gefitinib (ZD1839) for Cancer Assembloid Studies

  2026-09-02

  Use Gefitinib (ZD1839) as a mechanistic EGFR probe in matched tumor organoids and stromal-integrated assembloids, not only in conventional monolayers. This workflow helps distinguish direct tumor-cell sensitivity from microenvironment-driven resistance while connecting phospho-signaling data to viability, cell-cycle, and apoptosis outcomes.

• Tunicamycin and the UPR: Calibrating ER Stress

  2026-09-01

  Tunicamycin is a powerful N-glycosylation inhibitor for dissecting adaptive versus damaging ER stress. This article translates new C. elegans cadmium-resistance findings into practical assay logic without treating UPR activation as a simple on-or-off endpoint.

• Estradiol Workflows for Receptor–Autophagy Studies

  2026-09-01

  Build reproducible Estradiol assays that separate ERα and ERβ activity from vehicle effects, exposure artifacts, and autophagy-specific changes. This workflow translates multi-organ aging evidence into practical cell-based, pathway, and validation experiments.

7695 records 1/513 page Next 12345 下5页 Last page